Sarika Jain

Phase I study of alpelisib (BYL-719) and trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer (MBC) after trastuzumab and taxane therapy

Sarika Jain, Ami N. Shah, Cesar A. Santa‐Maria et al. · Breast Cancer Research and Treatment · 2018 · 152 citations

Medicine, Oncology, Pharmacology +16

A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer

Cesar August Santa-Maria, Taigo Kato, Jae‐Hyun Park et al. · Oncotarget · 2018 · 133 citations · Full text

Medicine, Immunology, Oncology +17

Phase II study of pembrolizumab and capecitabine for triple negative and hormone receptor-positive, HER2−negative endocrine-refractory metastatic breast cancer

Ami N. Shah, Lisa Flaum, Irene Helenowski et al. · Journal for ImmunoTherapy of Cancer · 2020 · 106 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579)

Virginia Kaklamani, Jacqueline S. Jeruss, Elisha Hughes et al. · Breast Cancer Research and Treatment · 2015 · 74 citations

Medicine, Oncology, Breast Oncology +13

Perceptions of care coordination in a population-based sample of diverse breast cancer patients

Sarah T. Hawley, Nancy K. Janz, Sarah E. Lillie et al. · Patient Education and Counseling · 2010 · 50 citations · Full text

Medicine, Oncology, Oncology Nursing +14